Wells Fargo & Company MN Increases Stake in U.S. Physical Therapy, Inc. (USPH)

Wells Fargo & Company MN boosted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 62.1% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 73,542 shares of the company’s stock after buying an additional 28,170 shares during the quarter. Wells Fargo & Company MN owned approximately 0.58% of U.S. Physical Therapy worth $4,519,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Pinebridge Investments L.P. lifted its stake in shares of U.S. Physical Therapy by 1.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after purchasing an additional 17 shares during the period. Sei Investments Co. lifted its stake in shares of U.S. Physical Therapy by 31.8% during the 2nd quarter. Sei Investments Co. now owns 2,576 shares of the company’s stock worth $155,000 after purchasing an additional 622 shares during the period. SG Americas Securities LLC purchased a new position in shares of U.S. Physical Therapy during the 3rd quarter worth $170,000. BlueCrest Capital Management Ltd purchased a new position in shares of U.S. Physical Therapy during the 2nd quarter worth $224,000. Finally, BNP Paribas Arbitrage SA lifted its stake in shares of U.S. Physical Therapy by 66.5% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,106 shares of the company’s stock worth $248,000 after purchasing an additional 1,640 shares during the period. 94.12% of the stock is currently owned by hedge funds and other institutional investors.

In related news, CFO Lawrance W. Mcafee sold 5,200 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $66.37, for a total transaction of $345,124.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Christopher J. Reading sold 15,000 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $66.52, for a total value of $997,800.00. The disclosure for this sale can be found here. Insiders have sold a total of 31,875 shares of company stock worth $2,173,623 over the last ninety days. 3.10% of the stock is currently owned by corporate insiders.

A number of research analysts have weighed in on the company. Cantor Fitzgerald reissued a “buy” rating and set a $80.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday. BidaskClub raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th. Zacks Investment Research lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Saturday, October 7th. Finally, Barrington Research lowered U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, November 3rd. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $73.80.

Shares of U.S. Physical Therapy, Inc. (USPH) opened at $74.95 on Friday. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $941.07, a price-to-earnings ratio of 45.15, a PEG ratio of 2.76 and a beta of 1.09. U.S. Physical Therapy, Inc. has a twelve month low of $56.50 and a twelve month high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, November 2nd. The company reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. The company had revenue of $103.03 million for the quarter, compared to analysts’ expectations of $102.69 million. research analysts predict that U.S. Physical Therapy, Inc. will post 2.07 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.dispatchtribunal.com/2018/01/13/wells-fargo-company-mn-boosts-holdings-in-u-s-physical-therapy-inc-usph.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply